XBiotech Inc. (XBIT)

NASDAQ: XBIT · IEX Real-Time Price · USD
8.13
+0.14 (1.75%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Total Valuation

XBiotech has a market cap or net worth of $248.17 million. The enterprise value is $48.15 million.

Market Cap 248.17M
Enterprise Value 48.15M

Important Dates

The last earnings date was Friday, March 15, 2024, after market close.

Earnings Date Mar 15, 2024
Ex-Dividend Date n/a

Share Statistics

XBiotech has 30.44 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Shares Outstanding 30.44M
Shares Change (YoY) -0.00%
Shares Change (QoQ) +0.02%
Owned by Insiders (%) 36.02%
Owned by Institutions (%) 15.15%
Float 17.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.13
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 33.07, with zero debt.

Current Ratio 33.07
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -10.80% and return on invested capital (ROIC) is -17.14%.

Return on Equity (ROE) -10.80%
Return on Assets (ROA) -10.50%
Return on Capital (ROIC) -17.14%
Revenue Per Employee n/a
Profits Per Employee -$299,476
Employee Count 82
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, XBiotech has paid $244,000 in taxes.

Income Tax 244,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +144.14% in the last 52 weeks. The beta is 1.43, so XBiotech's price volatility has been higher than the market average.

Beta (1Y) 1.43
52-Week Price Change +144.14%
50-Day Moving Average 6.00
200-Day Moving Average 4.97
Relative Strength Index (RSI) 78.27
Average Volume (30 Days) 48,126

Short Selling Information

The latest short interest is 585,312, so 1.92% of the outstanding shares have been sold short.

Short Interest 585,312
Short Previous Month 537,487
Short % of Shares Out 1.92%
Short % of Float 3.42%
Short Ratio (days to cover) 9.41

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -37.51M
Pretax Income -24.31M
Net Income -24.56M
EBITDA -22.57M
EBIT -24.31M
Earnings Per Share (EPS) -$0.81
Full Income Statement

Balance Sheet

The company has $200.02 million in cash and no debt, giving a net cash position of $200.02 million or $6.57 per share.

Cash & Cash Equivalents 200.02M
Total Debt n/a
Net Cash 200.02M
Net Cash Per Share $6.57
Equity / Book Value 218.85M
Book Value Per Share 7.19
Working Capital 195.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.73 million and capital expenditures -$362,000, giving a free cash flow of -$19.09 million.

Operating Cash Flow -18.73M
Capital Expenditures -362,000
Free Cash Flow -19.09M
FCF Per Share -$0.63
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XBiotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.00%
Shareholder Yield 0.00%
Earnings Yield -9.90%
FCF Yield -7.69%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2